Availability of different branded generic vildagliptin after off-patenting: An observation from India
Background: Branded generics offer comparable therapeutic benefits at a lower cost, making them essential in healthcare systems worldwide. Vildagliptin, a widely prescribed antidiabetic medication, is available in various branded generic forms. However, limited research has been conducted to assess...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of Diabetology |
Subjects: | |
Online Access: | http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2023;volume=14;issue=4;spage=236;epage=238;aulast=Samajdar |